August 18, 2022
The FDA has approved Akorn’s generic version of Merck’s Cetrotide® (cetrorelix acetate for injection) 0.25mg to prevent premature ovulation during controlled ovarian stimulation.
- Cetrotide first received FDA approval in Akorn’s 0.25mg strength generic is the first generic version of the drug.
- Recommended dosing is 25mg once daily during the early- to mid-follicular phase.
- Launch and pricing information are not yet available.